Rhode Island 2025 Regular Session Status: Died 10 D cosponsors

SB 222 — AN ACT RELATING TO INSURANCE -- PHARMACY FREEDOM OF CHOICE -- FAIR COMPETITION AND PRACTICES

Last action — 03/20/2025 Committee recommended measure be held for further study

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. Died in session

This bill died with 2025 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Requires pharmacy benefit managers to reimburse pharmacist no less than national drug acquisition costs plus fee.

Bill Text

We don't have the full text on file for this bill yet.

Read SB 222 on the official Rhode Island source →

Action History

  1. 03/20/2025 Committee recommended measure be held for further study

  2. 03/14/2025 Scheduled for hearing and/or consideration (03/20/2025)

  3. 02/10/2025 Introduced, referred to Senate Health and Human Services

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

10 sponsors · 0 co-sponsors · 104 not signed on

Sponsors (10)

Co-sponsors (0)

None.

Not signed on (104)

104 members have not signed on to this bill.

Show all 104 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

labor health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 222 do?
Requires pharmacy benefit managers to reimburse pharmacist no less than national drug acquisition costs plus fee.
Who sponsors SB 222?
SB 222 is sponsored by Tiara T. Mack (Democratic), Jonathon Acosta (Democratic), Bridget Valverde (Democratic), Pamela J. Lauria (Democratic), Melissa Murray (Democratic), Ana B. Quezada (Democratic), Walter S. Felag Jr. (Democratic), Samuel W. Bell (Democratic), Louis P. DiPalma (Democratic), and Linda L. Ujifusa (Democratic).
What is the current status of SB 222?
This bill died with 2025 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track SB 222?
Track SB 222 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 222

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 222

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →